Ignite Creation Date:
2025-12-25 @ 12:54 AM
Ignite Modification Date:
2026-02-22 @ 9:18 AM
Study NCT ID:
NCT02245867
Status:
COMPLETED
Last Update Posted:
2025-02-07
First Post:
2014-09-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients With AL Amyloidosis
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10-30
Start Date Type:
ACTUAL
Primary Completion Date:
2017-07-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-07-13
Completion Date Type:
ACTUAL
First Submit Date:
2014-09-15
First Submit QC Date:
None
Study First Post Date:
2014-09-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-05
Last Update Post Date:
2025-02-07
Last Update Post Date Type:
ACTUAL